Skip to main content
Home
  • Studies
    • Education
    • Faculties
    • Get informed
    • Admission
    • Student life
    • International student
    • Studies
  • Research
    • Entities
    • Research & Development
    • Innovation & Partnerships
    • Publications
    • Careers & funding
    • International
    • Research
  • The University
    • Brexit : What consequences for the university?
    • COVID info
    • Get to know UCLouvain
    • Facilities & access
    • Learning resources
    • Societal engagement
    • Working @ UCL
    • Alumni Louvain
    • The University
  • Infos COVID-19
  • My UCL
  • en
    Louvain Drug Research Institute
    Home

    Louvain Drug Research Institute

    • Infos COVID-19
    • My UCL
    • Université catholique de Louvain
      • Studies
      • Research
      • The
        University
    • Louvain Drug Research Institute
      • About
        • Administrative Organization
        • Publications
        • Seminars and thesis defences
        • Scientific reports
      • Research topics
        • Microbes
        • Cancer
        • Inflammation
        • Ageing and Chronic diseases
        • Advanced technologies
      • Research groups
        • Advanced Drug Delivery and Biomaterials (ADDB)
        • Bioanalysis and Pharmacology of Bioactive Lipids (BPBL)
        • Biomedical Magnetic Resonance (REMA)
        • Medicinal Chemistry (CMFA)
        • Metabolism & Nutrition (MNut)
        • Pharmacognosy (GNOS)
        • Translational Research from Experimental and Clinical Pharmacology to Treatment Optimization (TFAR)
      • Support us
      • Contact&Access
        • Contact
        • How to reach us
      • Vacant positions
        • Archive jobs
      • LDRI Intranet
    • In detail
      • New anticoagulants
      • Immunosupressants used in renal transplantation
      • Statins
      • Anti-HIV drugs
    • Return to parent page
    • About
        • Administrative Organization
        • Publications
        • Seminars and thesis defences
        • Scientific reports
    • Research topics
        • Microbes
        • Cancer
        • Inflammation
        • Ageing and Chronic diseases
        • Advanced technologies
    • Research groups
        • Advanced Drug Delivery and Biomaterials (ADDB)
        • Bioanalysis and Pharmacology of Bioactive Lipids (BPBL)
        • Biomedical Magnetic Resonance (REMA)
        • Medicinal Chemistry (CMFA)
        • Metabolism & Nutrition (MNut)
        • Pharmacognosy (GNOS)
        • Translational Research from Experimental and Clinical Pharmacology to Treatment Optimization (TFAR)
    • Support us
    • Contact&Access
        • Contact
        • How to reach us
    • Vacant positions
        • Archive jobs
    • LDRI Intranet
    1. UCL Home
    2. Research institutes
    3. Louvain Drug Research Institute
    4. Research groups
    5. Translational Research from Experimental and Clinical Pharmacology to Treatment Optimization (TFAR)
    6. Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics
    7. In detail
    Return to parent page
    • New anticoagulants
    • Immunosupressants used in renal transplantation
    • Statins
    • Anti-HIV drugs

    In detail

    Bruxelles Woluwe

    UCLouvain & You

    • Future student
    • PhD training
    • Researcher
    • Alumni
    • Fondation Louvain
    • Press

    About UCLouvain

    • About UCLouvain
    • Faculties
    • Research Institutes
    • Sites
    • Course catalogue
    • International

    UCLouvain everywhere else

    • Admission
    • Directories
    • Libraries
    • Agenda
    • Directions and contact information
    • Jobs
    Copyright 2021 -  Université catholique de Louvain  - Privacy  - Emergency
    © Université catholique de Louvain